The Gross Margin of Hanall Biopharma Co Ltd (009420.KS) is 52.76%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 52.76% |
| 2023-12-31 | 55.72% |
| 2022-12-31 | 56.34% |
| 2021-12-31 | 59.39% |
| 2020-12-31 | 57.17% |
| 2019-12-31 | 57.89% |
| 2018-12-31 | 53.38% |
| 2017-12-31 | 50.67% |
| 2016-12-31 | 46.46% |
| 2015-12-31 | 46.11% |